Home Healthcare Pharmaceuticals Nuclear Medicine Market

Nuclear Medicine Market Size, Share & Trends Analysis Report By Product (Diagnostics, Therapeutics), By Application (Cardiology, Therapeutic Applications, Neurology, Oncology, Thyroid, Lymphoma, Bone Metastasis, Endocrine Tumor, Pulmonary Scans, Urology, Other), By End Use (Hospitals, Diagnostic Centers, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: September 07, 2026 | Author: Debashree Bora | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Nuclear Medicine Market Size Analysis
    1. Introduction
    2. Nuclear Medicine Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Diagnostics
        1. SPECT
          1. TC-99m
          2. TL-201
          3. GA-67
          4. I-123
          5. Others
        2. PET
          1. F-18
          2. SR-82/RB-82
          3. PYLARIFY (piflufolastat F 18)
          4. Illuccix (gallium Ga 68 gozetotide)
          5. Others
      2. Therapeutics
        1. Alpha Emitters
          1. RA-223
          2. Others
        2. Beta Emitters
          1. I-131
          2. Y-90
          3. SM-153
          4. Re-186
          5. Lu-177
          6. Others
        3. Brachytherapy
          1. Cesium-131
          2. Iodine-125
          3. Palladium-103
          4. Iridium-192
          5. Others
    3. Nuclear Medicine Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Cardiology
        1. SPECT
        2. PET
      2. Therapeutic Applications
      3. Neurology
      4. Oncology
      5. Thyroid
        1. SPECT
        2. Therapeutic Applications
      6. Lymphoma
      7. Bone Metastasis
        1. SPECT
        2. Therapeutic Applications
      8. Endocrine Tumor
      9. Pulmonary Scans
      10. Urology
      11. Other
    4. Nuclear Medicine Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Diagnostic Centers
      3. Others
  7. North America Nuclear Medicine Market Size Analysis
    1. Introduction
    2. Nuclear Medicine Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Diagnostics
        1. SPECT
          1. TC-99m
          2. TL-201
          3. GA-67
          4. I-123
          5. Others
        2. PET
          1. F-18
          2. SR-82/RB-82
          3. PYLARIFY (piflufolastat F 18)
          4. Illuccix (gallium Ga 68 gozetotide)
          5. Others
      2. Therapeutics
        1. Alpha Emitters
          1. RA-223
          2. Others
        2. Beta Emitters
          1. I-131
          2. Y-90
          3. SM-153
          4. Re-186
          5. Lu-177
          6. Others
        3. Brachytherapy
          1. Cesium-131
          2. Iodine-125
          3. Palladium-103
          4. Iridium-192
          5. Others
    3. Nuclear Medicine Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Cardiology
        1. SPECT
        2. PET
      2. Therapeutic Applications
      3. Neurology
      4. Oncology
      5. Thyroid
        1. SPECT
        2. Therapeutic Applications
      6. Lymphoma
      7. Bone Metastasis
        1. SPECT
        2. Therapeutic Applications
      8. Endocrine Tumor
      9. Pulmonary Scans
      10. Urology
      11. Other
    4. Nuclear Medicine Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Diagnostic Centers
      3. Others
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
  8. Europe Nuclear Medicine Market Size Analysis
    1. Introduction
    2. Nuclear Medicine Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Diagnostics
        1. SPECT
          1. TC-99m
          2. TL-201
          3. GA-67
          4. I-123
          5. Others
        2. PET
          1. F-18
          2. SR-82/RB-82
          3. PYLARIFY (piflufolastat F 18)
          4. Illuccix (gallium Ga 68 gozetotide)
          5. Others
      2. Therapeutics
        1. Alpha Emitters
          1. RA-223
          2. Others
        2. Beta Emitters
          1. I-131
          2. Y-90
          3. SM-153
          4. Re-186
          5. Lu-177
          6. Others
        3. Brachytherapy
          1. Cesium-131
          2. Iodine-125
          3. Palladium-103
          4. Iridium-192
          5. Others
    3. Nuclear Medicine Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Cardiology
        1. SPECT
        2. PET
      2. Therapeutic Applications
      3. Neurology
      4. Oncology
      5. Thyroid
        1. SPECT
        2. Therapeutic Applications
      6. Lymphoma
      7. Bone Metastasis
        1. SPECT
        2. Therapeutic Applications
      8. Endocrine Tumor
      9. Pulmonary Scans
      10. Urology
      11. Other
    4. Nuclear Medicine Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Diagnostic Centers
      3. Others
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
    7. France
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
  9. APAC Nuclear Medicine Market Size Analysis
    1. Introduction
    2. Nuclear Medicine Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Diagnostics
        1. SPECT
          1. TC-99m
          2. TL-201
          3. GA-67
          4. I-123
          5. Others
        2. PET
          1. F-18
          2. SR-82/RB-82
          3. PYLARIFY (piflufolastat F 18)
          4. Illuccix (gallium Ga 68 gozetotide)
          5. Others
      2. Therapeutics
        1. Alpha Emitters
          1. RA-223
          2. Others
        2. Beta Emitters
          1. I-131
          2. Y-90
          3. SM-153
          4. Re-186
          5. Lu-177
          6. Others
        3. Brachytherapy
          1. Cesium-131
          2. Iodine-125
          3. Palladium-103
          4. Iridium-192
          5. Others
    3. Nuclear Medicine Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Cardiology
        1. SPECT
        2. PET
      2. Therapeutic Applications
      3. Neurology
      4. Oncology
      5. Thyroid
        1. SPECT
        2. Therapeutic Applications
      6. Lymphoma
      7. Bone Metastasis
        1. SPECT
        2. Therapeutic Applications
      8. Endocrine Tumor
      9. Pulmonary Scans
      10. Urology
      11. Other
    4. Nuclear Medicine Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Diagnostic Centers
      3. Others
    5. China
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
    8. India
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
  10. Middle East and Africa Nuclear Medicine Market Size Analysis
    1. Introduction
    2. Nuclear Medicine Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Diagnostics
        1. SPECT
          1. TC-99m
          2. TL-201
          3. GA-67
          4. I-123
          5. Others
        2. PET
          1. F-18
          2. SR-82/RB-82
          3. PYLARIFY (piflufolastat F 18)
          4. Illuccix (gallium Ga 68 gozetotide)
          5. Others
      2. Therapeutics
        1. Alpha Emitters
          1. RA-223
          2. Others
        2. Beta Emitters
          1. I-131
          2. Y-90
          3. SM-153
          4. Re-186
          5. Lu-177
          6. Others
        3. Brachytherapy
          1. Cesium-131
          2. Iodine-125
          3. Palladium-103
          4. Iridium-192
          5. Others
    3. Nuclear Medicine Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Cardiology
        1. SPECT
        2. PET
      2. Therapeutic Applications
      3. Neurology
      4. Oncology
      5. Thyroid
        1. SPECT
        2. Therapeutic Applications
      6. Lymphoma
      7. Bone Metastasis
        1. SPECT
        2. Therapeutic Applications
      8. Endocrine Tumor
      9. Pulmonary Scans
      10. Urology
      11. Other
    4. Nuclear Medicine Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Diagnostic Centers
      3. Others
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
  11. LATAM Nuclear Medicine Market Size Analysis
    1. Introduction
    2. Nuclear Medicine Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Diagnostics
        1. SPECT
          1. TC-99m
          2. TL-201
          3. GA-67
          4. I-123
          5. Others
        2. PET
          1. F-18
          2. SR-82/RB-82
          3. PYLARIFY (piflufolastat F 18)
          4. Illuccix (gallium Ga 68 gozetotide)
          5. Others
      2. Therapeutics
        1. Alpha Emitters
          1. RA-223
          2. Others
        2. Beta Emitters
          1. I-131
          2. Y-90
          3. SM-153
          4. Re-186
          5. Lu-177
          6. Others
        3. Brachytherapy
          1. Cesium-131
          2. Iodine-125
          3. Palladium-103
          4. Iridium-192
          5. Others
    3. Nuclear Medicine Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Cardiology
        1. SPECT
        2. PET
      2. Therapeutic Applications
      3. Neurology
      4. Oncology
      5. Thyroid
        1. SPECT
        2. Therapeutic Applications
      6. Lymphoma
      7. Bone Metastasis
        1. SPECT
        2. Therapeutic Applications
      8. Endocrine Tumor
      9. Pulmonary Scans
      10. Urology
      11. Other
    4. Nuclear Medicine Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Diagnostic Centers
      3. Others
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
          1. SPECT
            1. TC-99m
            2. TL-201
            3. GA-67
            4. I-123
            5. Others
          2. PET
            1. F-18
            2. SR-82/RB-82
            3. PYLARIFY (piflufolastat F 18)
            4. Illuccix (gallium Ga 68 gozetotide)
            5. Others
        2. Therapeutics
          1. Alpha Emitters
            1. RA-223
            2. Others
          2. Beta Emitters
            1. I-131
            2. Y-90
            3. SM-153
            4. Re-186
            5. Lu-177
            6. Others
          3. Brachytherapy
            1. Cesium-131
            2. Iodine-125
            3. Palladium-103
            4. Iridium-192
            5. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Cardiology
          1. SPECT
          2. PET
        2. Therapeutic Applications
        3. Neurology
        4. Oncology
        5. Thyroid
          1. SPECT
          2. Therapeutic Applications
        6. Lymphoma
        7. Bone Metastasis
          1. SPECT
          2. Therapeutic Applications
        8. Endocrine Tumor
        9. Pulmonary Scans
        10. Urology
        11. Other
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Others
  12. Competitive Landscape
    1. Nuclear Medicine Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. GE Healthcare
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Jubilant Life Sciences Ltd
    3. Molecular Partners
    4. Nordion (Canada), Inc.
    5. Bracco Imaging S.P.A
    6. Starget Pharma
    7. The institute for radioelements (IRE)
    8. NTP Radioisotopes SOC Ltd.
    9. The Australian Nuclear Science and Technology Organization
    10. Eczacıbaşı-Monrol
    11. Lantheus Medical Imaging, Inc
    12. Eckert & Ziegler
    13. Mallinckrodt
    14. Cardinal Health
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer

List of Tables

Table 1: Global Nuclear Medicine Market Size and Forecast By Regions - 2022-2034 (USD Billion)

Table 2: Global Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 3: Global Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 4: Global Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 5: North America Nuclear Medicine Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 6: North America Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 7: North America Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 8: North America Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 9: U.S. Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 10: U.S. Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 11: U.S. Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 12: Canada Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 13: Canada Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 14: Canada Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 15: Europe Nuclear Medicine Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 16: Europe Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 17: Europe Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 18: Europe Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 19: U.K. Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 20: U.K. Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 21: U.K. Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 22: Germany Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 23: Germany Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 24: Germany Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 25: France Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 26: France Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 27: France Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 28: Spain Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 29: Spain Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 30: Spain Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 31: Italy Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 32: Italy Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 33: Italy Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 34: Russia Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 35: Russia Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 36: Russia Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 37: Nordic Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 38: Nordic Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 39: Nordic Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 40: Benelux Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 41: Benelux Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 42: Benelux Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 43: Rest of Europe Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 44: Rest of Europe Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 45: Rest of Europe Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 46: APAC Nuclear Medicine Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 47: APAC Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 48: APAC Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 49: APAC Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 50: China Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 51: China Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 52: China Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 53: Korea Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 54: Korea Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 55: Korea Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 56: Japan Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 57: Japan Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 58: Japan Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 59: India Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 60: India Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 61: India Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 62: Australia Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 63: Australia Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 64: Australia Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 65: Taiwan Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 66: Taiwan Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 67: Taiwan Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 68: South East Asia Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 69: South East Asia Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 70: South East Asia Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 71: Rest of Asia-Pacific Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 72: Rest of Asia-Pacific Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 73: Rest of Asia-Pacific Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 74: Middle East and Africa Nuclear Medicine Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 75: Middle East and Africa Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 76: Middle East and Africa Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 77: Middle East and Africa Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 78: UAE Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 79: UAE Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 80: UAE Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 81: Turkey Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 82: Turkey Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 83: Turkey Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 84: Saudi Arabia Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 85: Saudi Arabia Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 86: Saudi Arabia Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 87: South Africa Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 88: South Africa Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 89: South Africa Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 90: Egypt Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 91: Egypt Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 92: Egypt Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 93: Nigeria Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 94: Nigeria Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 95: Nigeria Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 96: Rest of MEA Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 97: Rest of MEA Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 98: Rest of MEA Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 99: LATAM Nuclear Medicine Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 100: LATAM Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 101: LATAM Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 102: LATAM Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 103: Brazil Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 104: Brazil Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 105: Brazil Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 106: Mexico Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 107: Mexico Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 108: Mexico Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 109: Argentina Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 110: Argentina Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 111: Argentina Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 112: Chile Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 113: Chile Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 114: Chile Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 115: Colombia Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 116: Colombia Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 117: Colombia Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 118: Rest of LATAM Nuclear Medicine Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 119: Rest of LATAM Nuclear Medicine Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 120: Rest of LATAM Nuclear Medicine Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.